Advances in understanding the pathophysiology of autism spectrum disorders K Yenkoyan, A Grigoryan, K Fereshetyan, D Yepremyan Behavioural brain research 331, 92-101, 2017 | 148 | 2017 |
A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders K Yenkoyan, H Harutyunyan, A Harutyunyan Free Radical Biology and Medicine 123, 85-95, 2018 | 66 | 2018 |
Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder K Fereshetyan, V Chavushyan, M Danielyan, K Yenkoyan Scientific reports 11 (1), 23471, 2021 | 42 | 2021 |
Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders—Therapeutic potential or a mirage? A Gladkevich, F Bosker, J Korf, K Yenkoyan, H Vahradyan, M Aghajanov Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (7), 1347-1355, 2007 | 42 | 2007 |
Modeling neurodegenerative disorders in zebrafish AA Bashirzade, KN Zabegalov, AD Volgin, AS Belova, KA Demin, ... Neuroscience & Biobehavioral Reviews 138, 104679, 2022 | 40 | 2022 |
Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats K Yenkoyan, K Safaryan, V Chavushyan, I Meliksetyan, G Navasardyan, ... Brain research bulletin 86 (3-4), 262-271, 2011 | 40 | 2011 |
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 39 | 2022 |
Intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats HJ Drews, K Yenkoyan, A Lourhmati, M Buadze, D Kabisch, ... Neurotherapeutics 16, 725-740, 2019 | 39 | 2019 |
Effects of beta-amyloid on behavioral and amino acids spectrum in rats’ brain and their modulation by embryonic proteins K Yenkoyan, K Safaryan, G Navasardyan, L Mkrtchyan, M Aghajanov Neurochemistry international 54 (5-6), 292-298, 2009 | 24 | 2009 |
Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients M Movsisyan, A Chopikyan, I Kasparova, G Hakobjanyan, F Carrat, ... Scientific Reports 12 (1), 12403, 2022 | 20 | 2022 |
The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells G Karapetyan, K Fereshetyan, H Harutyunyan, K Yenkoyan Scientific Reports 12 (1), 17883, 2022 | 19 | 2022 |
The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide K Yenkoyan, K Fereshetyan, S Matinyan, V Chavushyan, M Aghajanov Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 76-82, 2018 | 19 | 2018 |
Brain-derived neurotrophic factor (BDNF) in perinatal depression: side show or pivotal factor? S Singh, K Fereshetyan, S Shorter, R Paliokha, E Dremencov, ... Drug Discovery Today 28 (2), 103467, 2023 | 18 | 2023 |
Novel probable glance at inflammatory scenario development in autistic pathology AA Harutyunyan, HA Harutyunyan, KB Yenkoyan Frontiers in Psychiatry 12, 788779, 2021 | 17 | 2021 |
Neuroprotective, neurogenic, and amyloid beta reducing effect of a novel alpha 2-Adrenoblocker, mesedin, on astroglia and neuronal progenitors upon hypoxia and glutamate exposure MM Melkonyan, L Hunanyan, A Lourhmati, N Layer, S Beer-Hammer, ... International Journal of Molecular Sciences 19 (1), 9, 2017 | 15 | 2017 |
α2-Adrenergic receptor in liver fibrosis: implications for the adrenoblocker mesedin UA Schwinghammer, MM Melkonyan, L Hunanyan, R Tremmel, ... Cells 9 (2), 456, 2020 | 14 | 2020 |
Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a … M Aghajanov, V Chavushyan, S Matinyan, M Danielyan, K Yenkoyan Neurochemistry International 131, 104531, 2019 | 14 | 2019 |
Current state of modeling human psychiatric disorders using zebrafish FV Costa, TO Kolesnikova, DS Galstyan, NP Ilyin, MS de Abreu, ... International Journal of Molecular Sciences 24 (4), 3187, 2023 | 11 | 2023 |
Disruption of cholinergic circuits as an area for targeted drug treatment of Alzheimer’s disease: In vivo assessment of short-term plasticity in rat brain V Chavushyan, A Soghomonyan, G Karapetyan, K Simonyan, ... Pharmaceuticals 13 (10), 297, 2020 | 9 | 2020 |
Towards novel potential molecular targets for antidepressant and antipsychotic pharmacotherapies YM Kositsyn, MS de Abreu, TO Kolesnikova, AA Lagunin, VV Poroikov, ... International Journal of Molecular Sciences 24 (11), 9482, 2023 | 8 | 2023 |